Opportunities for consolidation in the German diagnostic labs sector have almost dried up, according to a large lab operator. But the market as a whole will continue to grow strongly post-Covid, with revenue up as much as 4-5% per annum, he said.
The German healthcare M&A market continues to be buoyant following the boom in 2021. But as autumn draws in, the pace of deals may abate and sellers may struggle to achieve previous heady price premiums, advisors warn.
HBI hears that pan-European and dentist-led European Dental Group (EDG) could be up for sale soon. HBI takes a look at the business and possible pricing at a time when dentistry continues to be a hot ticket.
Germany-based healthcare conglomerate Fresenius tells HBI it isn't currently looking to carve off parts of its business for sale, and despite mixed H1 results it sees plenty of opportunities for growth.
The number of hospitals losing money will more than double to 59% in 2022 and the situation is likely to get far worse as the Covid block payment comfort cushion has been removed. Meanwhile, statutory insurers face huge deficits, hospital productivity is falling and vacancies increasing. The annual 2022 hospital rating report from the Leibniz Institute of Economic Research and the Institute for Healthcare Business paints a truly dire picture.
Naxicap-owned imaging group 3R Réseau Radiologique Romand has bought IRIS Radiologie and is eyeing up France. Germany and Italy are also possibles, HBI hears.
Germany-based multinational healthcare group Fresenius SE is reportedly leaning towards splitting off hospital branch Fresenius Helios and merging it with a competitor hospital chain in order to grow the business and increase its profitability. A spokesperson for the group tells us any such deal would involve Fresenius SE staying on as majority shareholder.
The attraction of the DACH region (Germany, Austria and Switzerland) for investors is clear, yet despite there being a willingness to pay for extra services across the region, the coming economic crisis does present a unique set of challenges to each country.
Profound pessimism about NHS plans for integrated health and with NHS systems in the UK and Canada was on display from academics at the European Health Policymakers Group which celebrated its 21st year in an afternoon looking at what the group had learnt studying Beveridge (NHS) and Bismarckian (statutory insurer) models.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
